HYFT
ImmunoPrecise Antibodies Ltd.
1.50$
-3.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -354.0% | – | – | – | – | – | – | – | – | – | |
| – | -21.3% | -26.3% | +29.8% | -63.8% | +201.5% | -39.6% | +20.2% | +51.7% | +5.0% | +146.0% | -45.3% | -30.1% | +27.7% | -22.2% | -20.8% | -42.1% | +12.8% | -27.2% | +3,927.0% | +20.8% | +805.1% | +394.1% | +50.6% | +8.9% | +1.5% | +77.4% | -14.2% | -10.7% | -69.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -73.5% | – | – | – | – | – | – | – | +516.8% | -8.8% | -33.7% | +271.8% | +12.2% | -37.0% | -21.0% | -71.0% | +186.5% | |
| – | -150.7% | – | – | – | -187.9% | – | – | – | -2.8% | -180.2% | – | – | – | – | +247.9% | +9.7% | -139.9% | – | +107,114.9% | +430.0% | -150.8% | – | -292.6% | – | – | -662.9% | – | -88.5% | -831.6% | |
| – | +107.6% | -66.0% | -58.0% | +354.1% | -98.7% | +1,582.0% | +71.7% | +235.2% | +114.9% | -1.3% | -94.2% | +1,222.7% | -76.8% | -95.8% | -88.0% | -100.0% | – | – | -14.0% | +2,936.3% | -34.9% | +86.7% | -10.8% | +147.9% | -11.9% | +18.9% | -6.6% | -42.8% | -51.0% | |
| – | – | -136.4% | -51.7% | +453.8% | – | -214.6% | +62.7% | +243.1% | +121.5% | -1.3% | -98.1% | +3,570.9% | -81.6% | – | -66.8% | – | – | – | +13,498.0% | +114.0% | +4,007.5% | -69.3% | -28.1% | +55.1% | +112.1% | -62.2% | -20.5% | -48.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -67.5% | +38.5% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +39.0% | +0.1% | – | -129.3% | |
| – | -100.0% | +229.3% | +1,667.5% | +2,583.4% | -86.5% | +208.2% | +212.9% | +208.8% | -97.4% | +2,338.8% | -78.3% | +371.9% | – | – | – | – | – | -100.8% | +15,217.8% | – | +209.5% | -4.6% | -98.1% | +24,730.4% | -93.4% | -121.5% | – | +1,358.7% | -99.2% | |
| – | – | -190.5% | – | – | – | – | – | +282.6% | -194.1% | – | – | – | -220.2% | – | – | – | – | -239.6% | – | +1,653.1% | -134.5% | – | -176.3% | – | -130.1% | – | – | – | -88.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -569.8% | – | – | – | – | – | – | – | – | – |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.